Trading Tips Blog

James Gorman, a director at The Walt Disney Company (DIS), recently bought 20,000 shares. The buy increased the director’s stake by over 1,000%, and came to a total cost of $2.1 million. This is the first insider buy at Disney since another director bought 1,078 shares for just over $99,900 back in December 2023. Otherwise, company insiders have been modest sellers of shares, with executives typically selling following the exercise of stock options. Overall, Disney insiders own just under 0.01% of ...
Read More About This

Commerce platform Shopify (SHOP) fell last week following earnings. As a result, shares are now trading flat over the past year. One trader is betting shares will rebound from the earnings drop in the months ahead. That’s based on the September $120 calls. With 129 days until expiration, 12,376 contracts traded compared to a prior open interest of 444, for a 28-fold rise in volume on the trade. The buyer of the calls paid $0.14 to make the bullish bet. Shopify shares ...
Read More About This

Markets tend to get jittery during earnings season. In the long-term, earnings matter. In the short-term, other factors may be at play. That can include how a company discusses its forward outlook. Or there may be some aspect to a company’s revenues or profit margins that lead to a selloff. Fortunately, that’s an opportunity for investors. While short-term traders may beat down shares of a great company, its creates a buying opportunity for those with a bullish outlook. For instance, metaverse video ...
Read More About This

Michael Pegram, a director at Caesars Entertainment (CZR), recently bought 40,000 shares. The buy increased his take by 25%, and came to a total cost of $1.45 million. That’s the second buy from the director this year, following a 15,000 share buy in March at a cost just over $621,000. He was also a buyer twice in 2023, along with the company CEO, who bought $370,725 of shares. In the past year, there has been just one insider sale. Overall, Caesars ...
Read More About This

Health diagnostics company Exact Sciences Corp (EXAS) is down nearly 25% in the past year. One trader is betting on a further decline in the coming weeks. That’s based on the June $50 puts. With 38 days until expiation, 2,758 contracts traded compared to a prior open interest of 108, for a 25-fold rise in volume on the trade. The buyer of the puts paid $1.46 to make the bearish bet. Exact shares recently traded for about $54, so the stock would ...
Read More About This

Every industry will have several players. Depending on the structure of the industry, there may be dozens of players or just a few. The ease of entering the industry and successfully competing can make a big difference. That’s why the restaurant industry has dozens of options. But the credit card networks have just four players due to the high cost of entry and building a network. Today’s tech companies often have just a handful of players. That’s because these companies can successfully ...
Read More About This

David MacLennan, a director at Caterpillar (CAT), recently bought 500 shares. The buy increased his position by 10%, and came to a total cost of $168,195. This is the director’s second buy of the year, following a 350 share pickup for just over $113,000 back in February. Otherwise, there has been one insider sale from a company Group President, following the exercise of stock options. Going further back, insiders were more likely to be sellers of Caterpillar stock. Overall, Caterpillar insiders ...
Read More About This

Drug manufacturer Teva Pharmaceutical (TEVA) has been on a tear, with shares soaring 67% over the past year. One trader sees shares continuing higher into the autumn. That’s based on the September $18 calls. With 133 days until expiration, 7,964 contracts traded compared to a prior open interest of 171, for a 47-fold rise in volume on the trade. The buyer of the calls paid $0.71 to make the bullish bet. Teva shares recently soared to a 52-week high just under ...
Read More About This